DOCSLIB.ORG

PADI3 Induces Cell Cycle Arrest Via the Sirt2/AKT/P21 Pathway and Acts As a Tumor Suppressor Gene in Colon Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PADI3 Induces Cell Cycle Arrest Via the Sirt2/AKT/P21 Pathway and Acts As a Tumor Suppressor Gene in Colon Cancer Cancer Biol Med 2019. doi: 10.20892/j.issn.2095-3941.2019.0065 ORIGINAL ARTICLE PADI3 induces cell cycle arrest via the Sirt2/AKT/p21 pathway and acts as a tumor suppressor gene in colon cancer Xiaotian Chang1,2, Zhengbin Chai3, Jiaorui Zou1, Hongxing Wang1, Yao Wang1, Yabing Zheng1, Hui Wu1, Chunyan Liu1 1Medical Research Center, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China; 2Medical Research Center of the Hospital Affiliated to Qingdao University, Qingdao 266000, China; 3Department of Laboratory Medicine, Jinan Infectious Disease Hospital, Shandong University, Jinan 250021, China ABSTRACT Objective: As a member of the peptidyl arginine deiminase (PAD) family, PADI3 is weakly expressed in colon cancer tissues and highly expressed in adjacent colon cancer tissues. However, the role of PADI3 in colon cancer is unclear. In this study, we investigated the function and molecular mechanism of PADI3 in colon cancer tumorigenesis. Methods: Western blot and real-time PCR were used to detect the expression levels of several genes. CCK-8, flow cytometry (FCM) and colony formation assays were used to examine cell proliferation, the cell cycle and colony formation ability. RNA- sequencing analysis was used to study the molecular mechanism of PADI3 in tumorigenesis. A truncation mutation experiment was performed to determine the key functional domain of PADI3. Results: PADI3 overexpression inhibited cell proliferation and colony formation and led to G1 phase arrest in both HCT116 (originating from primary colon cancer) and LoVo (originating from metastatic tumor nodules of colon cancer) cells. PADI3- expressing HCT116 cells had a lower tumor formation rate and produced smaller tumors than control cells. PADI3 significantly decreased Sirtuin2 (Sirt2) and Snail expression and AKT phosphorylation and increased p21 expression, and Sirt2 overexpression partly reversed the effects induced by PADI3 overexpression. Immunocytochemistry showed that PADI3 is mainly localized in the cytoplasm. Truncation mutation experiments showed that the C-domain is the key domain involved in the antitumor activity of PADI3. Conclusions: PADI3 suppresses Snail expression and AKT phosphorylation and promotes p21 expression by downregulating Sirt2 expression in the cytoplasm, and the C-domain is the key domain for its antitumor activity. KEYWORDS PADI3; Sirt2; colon cancer; cell cycle; C-domain Introduction Citrullination, a posttranslational modification, is catalyzed by a group of enzymes called peptidyl arginine Colorectal cancer (CRC) is a disease with high mortality deiminases (PADs). PADs are reported to be involved in worldwide1,2, but the pathogenesis of CRC remains unclear3. various biological processes in numerous human diseases, Surgical interventions, chemotherapy and radiotherapy are such as rheumatoid arthritis6, Alzheimer’s disease7, ulcerative the major treatments for CRC in the clinic. Despite these colitis8, and cancers9,10. The PAD family comprises five treatments, the poor prognosis associated with metastasis and members: PADI1, PADI2, PADI3, PADI4 and PADI6. Many recurrence postsurgery has not improved4,5. Further study of reports have shown that PADI1, PADI2 and PADI4 are the molecular mechanism of colon cancer, the identification involved in the tumorigenesis of various cancers10-13, and of colon cancer-suppressing genes, and methods to improve PADI6 is involved in early embryonic development14. PADI3 the survival rate of patients are issues that urgently need to be has been reported to be expressed in human keratinocytes addressed. and plays an important role in uncombable hair syndrome15,16. However, the role of PADI3 in tumorigenesis is poorly understood. Correspondence to: Chunyan Liu In the present study, we found that PADI3 is highly E-mail: [email protected] Received February 26, 2019; accepted May 6, 2019. expressed in adjacent colon tissues, but only a small amount Available at www.cancerbiomed.org of PADI3 expression can be detected in colon cancer tissues. Copyright © 2019 by Cancer Biology & Medicine We therefore further investigated the function of PADI3 in 730 Chang et al. PADI3 induces G1-arrest via Sirt2/AKT/p21 pathway the tumorigenesis of colon cancer. In vitro, the the Ethics Committee of Shandong Province Qianfoshan overexpression of PADI3 inhibited cell proliferation by Hospital, Jinan, China (Approval No. S0087). inducing G1 phase arrest. In vivo, PADI3-expressing HCT116 cells showed a lower tumor formation ratio and Primers and antibodies produced smaller tumors compared with the control group. We speculate that PADI3 plays an antitumor role in colon Full-length of PADI3 was amplified using PCR with the cancer. Further study showed that PADI3 can significantly primers PADI3-EcoRI-Fex and PADI3-AscI-Rex, the N- suppress Sirt2 expression at both the transcriptional and domain was amplified with the primers PADI3-N-OE- translational levels. However, the molecular mechanism of EcoRI-Fex and PADI3-N-OE-AscI-Rex, the M-domain was this process is still poorly understood. amplified with the primers PADI3-M-OE-EcoRI-Fex and + Sirt2 belongs to the Sirtuin family, which possesses NAD - PADI3-M-OE-AscI-Rex, the C-domain was amplified with 17 dependent protein deacetylase activity . Sirt2 participates in the primers PADI3-C-OE-EcoRI-Fex and PADI3-C-OE- a variety of cellular processes, including the cell cycle, the AscI-Rex, the NM-domain was amplified with the primers mitotic checkpoint, autophagy, apoptosis, migration and PADI3-N-OE-EcoRI-Fex and PADI3-M-OE-AscI-Rex, and 18-20 invasion . Sirt2 is highly expressed in multiple the MC-domain was amplified with the primers PADI3-M-OE- 21-23 tumors . Increasing evidence has demonstrated that Sirt2 EcoRI-Fex and PADI3-C-OE-AscI-Rex. The primer sequences plays an important role in tumorigenesis, but the function of were designed as shown in Supplementary Table S1. Sirt2 in tumorigenesis is still under debate17,21,24-26. The The following primary antibodies used in this study were opposing functions of Sirt2 in tumorigenesis may be commercially obtained: anti-PADI3 (Abcam, ab172959), dependent on the tissue distribution of it. anti-GAPDH (Abcam, ab181603), anti-AKT (Santa Cruz Inhibitors of Sirt2, such as TM, AK1, AGK-2, AC-93253, Biotechnology, sc5298), anti-Sirt2 (Santa Cruz AEM1, AEM2, and Tenovin-D3, have been proven to Biotechnology, sc28298), anti-p21 (Santa Cruz suppress tumorigenesis in a variety of tumors17,23,27-32. Biotechnology, sc6246), anti-phosphorylated AKT (p-AKT) According to a previous study, effective Sirt2 inhibitors are (CST, #4060), anti-Snail (CST, #3879), anti-His-tag (CST, considered to be the most promising cancer treatment. In 12698S), anti-histone 3 (Affinity, AF0863) and anti-red colon cancer, suppressing Sirt2 expression can induce cell fluorescent protein (RFP) (Abcam, ab28664). The following cycle arrest17, promote cell apoptosis33, and inhibit tumor secondary antibodies were used in this study: goat anti-rabbit angiogenesis34. Suppressing Sirt2 expression may be a wise choice in colon cancer therapy. Based on the above results, (Affinity, #s0001), goat anti-mouse (Affinity, #s0002) and we speculate that PADI3 has antitumor activity as a Sirt2 donkey anti-goat (Abcam, ab6881). inhibitor, but the molecular mechanism is still unclear. Further study showed that PADI3 can significantly Quantitative real-time-PCR analysis decrease Snail expression and AKT phosphorylation while increasing p21 expression via the downregulation of Sirt2 The total RNA of cells or tissues was extracted using Trizol expression. Truncation mutation and immunocytochemistry reagent (Life Technologies, USA). The extracted RNA was showed that PADI3 exerts its antitumor activity mainly in the reverse-transcribed into first-strand cDNA in a final volume cytoplasm and that the C-domain is the key functional of 10 μL using an RNA PCR Kit (Toyobo, Japan). The domain of PADI3. reverse-transcribed first-strand cDNA was used as the These findings indicate that PADI3 exerts its antitumor template for real-time PCR with the forward primer PADI3- activity by suppressing Sirt2 expression in the cytoplasm and QF and the reverse primer PADI3-QR; the primer sequences that the C-domain is essential for PADI3 to exert its are shown in Supplementary Table S1. The conditions of antitumor activity. real-time PCR were as follows: 10 s at 95°C; 45 cycles of 5 s at 60°C and 10 s at 72°C; and 30 s at 65°C. This experiment was Materials and methods performed in triplicate. Real-time PCR was performed using a 10 μL total volume that contained 1 μL of cDNA, 2 μL of Animals ddH2O, 5 μL of SYBR Green Real-time PCR Master Mix (Toyobo, Japan), 1 μL of forward primer and 1 μL of reverse BALB/c nude mice were housed in an Association for primer. GAPDH was used for quantity and quality control Assessment and Accreditation of Laboratory Animal Care using the forward primer of human GAPDH-QF and the (AAALAC)-accredited facility. The study was approved by reverse primer of human GAPDH-QR. The primer sequences Cancer Biol Med Vol 16, No 4 November 2019 731 are shown in Supplementary Table S1. Data were analyzed The absorbance was measured at 450 nm with a using the formula R = 2−[ΔCt sample − ΔCt control], where R is the spectrophotometer (SpectraMax 190, Molecular Devices, relative expression level, ΔCt sample is the difference between USA). Graphs showing growth were generated from the the Ct of the gene and the average GAPDH in the experiment average values of five wells in each group. sample, and ΔCt control is the difference between the Ct of the gene and the average GAPDH in the control sample. Cell colony formation assay Western blot analysis HCT116 cells were transfected with pCDNA3.1-PADI3-RFP plasmids to overexpress PADI3, and HCT116 cells One hundred micrograms of tumor tissue was homogenized transfected with pCDNA3.1-RFP plasmids were used as in 600 μL of Cell Lysis Solution (Sigma-Aldrich, USA) and controls. Following transfection for 48 h, the cells were centrifuged at 12,000 rpm for 20 min at 4°C.
Load more

Recommended publications
  • Universidad Autónoma De Madrid Regulatory Mechanisms of Germinal Centers
    Universidad Autónoma de Madrid Departamento de Biología Molecular Regulatory mechanisms of Germinal Centers PhD Thesis Arantxa Pérez García Madrid, 2016 Regulatory mechanisms of Germinal Centers Memoria presentada por la licenciada en Biología Arantxa Pérez García para optar al título de doctor por la Universidad Autónoma de Madrid Directora de tesis: Almudena R. Ramiro Este trabajo ha sido realizado en el laboratorio de Biología de linfocitos B, en el Centro Nacional de Investigaciones Cardiovasculares (CNIC) Madrid, 2016 Memoria presentada por Arantxa Pérez García, licenciada en Biología, para optar al grado de doctor por la Universidad Autónoma de Madrid. Esta tesis ha sido realizada en el laboratorio de Biología de Linfocitos B del Centro Nacional de Investigaciones Cardiovasculares (CNIC), bajo la dirección de la Doctora Almudena R. Ramiro, y para que así conste y a los efectos oportunos, firma el siguiente certificado; En Madrid, a 21 de Abril de 2016 Almudena R. Ramiro RESUMEN Tras el reconocimiento del antígeno, los linfocitos B pueden iniciar la reacción de centro germinal (GC), en la cual diversifican sus genes de inmunoglobulinas, mediante las reacciones de hipermutación somática (SHM) y cambio de isotipo (CSR), dando lugar a células plasmáticas o B memoria. La transición a través de los diferentes estadios de esta reacción implica la expresión coordinada de redes de genes que permiten una correcta diversificación de los linfocitos B. A nivel molecular, las reacciones de SHM y CSR se desencadenan por la desaminación de citosinas en los genes de las inmunoglobulinas, mediada por AID. La actividad de AID en linfocitos B no está restringida a los genes de las inmunoglobulinas, pudiendo introducir mutaciones en otros genes y mediar translocaciones cromosómicas con potencial linfomagénico.
    [Show full text]
  • Supp Material.Pdf
    Simon et al. Supplementary information: Table of contents p.1 Supplementary material and methods p.2-4 • PoIy(I)-poly(C) Treatment • Flow Cytometry and Immunohistochemistry • Western Blotting • Quantitative RT-PCR • Fluorescence In Situ Hybridization • RNA-Seq • Exome capture • Sequencing Supplementary Figures and Tables Suppl. items Description pages Figure 1 Inactivation of Ezh2 affects normal thymocyte development 5 Figure 2 Ezh2 mouse leukemias express cell surface T cell receptor 6 Figure 3 Expression of EZH2 and Hox genes in T-ALL 7 Figure 4 Additional mutation et deletion of chromatin modifiers in T-ALL 8 Figure 5 PRC2 expression and activity in human lymphoproliferative disease 9 Figure 6 PRC2 regulatory network (String analysis) 10 Table 1 Primers and probes for detection of PRC2 genes 11 Table 2 Patient and T-ALL characteristics 12 Table 3 Statistics of RNA and DNA sequencing 13 Table 4 Mutations found in human T-ALLs (see Fig. 3D and Suppl. Fig. 4) 14 Table 5 SNP populations in analyzed human T-ALL samples 15 Table 6 List of altered genes in T-ALL for DAVID analysis 20 Table 7 List of David functional clusters 31 Table 8 List of acquired SNP tested in normal non leukemic DNA 32 1 Simon et al. Supplementary Material and Methods PoIy(I)-poly(C) Treatment. pIpC (GE Healthcare Lifesciences) was dissolved in endotoxin-free D-PBS (Gibco) at a concentration of 2 mg/ml. Mice received four consecutive injections of 150 μg pIpC every other day. The day of the last pIpC injection was designated as day 0 of experiment.
    [Show full text]
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data
    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
    [Show full text]
  • Is the Loose Anagen Hair Syndrome a Keratin Disorder? a Clinical and Molecular Study
    STUDY Is the Loose Anagen Hair Syndrome a Keratin Disorder? A Clinical and Molecular Study Vale´rie Chapalain, MD; Hermelita Winter, PhD; Lutz Langbein, PhD; Jean-Michel Le Roy, MD; Christine Labre`ze, MD; Milos Nikolic, MD; Ju¨rgen Schweizer, PhD; Alain Taı¨eb, MD Objectives: To report the clinical features of the loose seldom cut their hair, and 4 had unmanageable hair. One anagen hair syndrome and to test the hypothesis that the patient had hypodontia. Two patients had an additional typical gap between the hair and the inner root sheath clinical phenotype of diffuse partial woolly hair. The fam- may result from hereditary defects in the inner root sheath ily history was positive for loose anagen hair syndrome or the apposed companion layer. in 5 patients. Marked improvement was noted after treat- ment with 5% minoxidil lotion in 7 of the 11 patients Design: Case series. treated. Polymerase chain reaction analysis of the gene segments encoding the ␣-helical 1A and 2B subdomains Setting: A pediatric dermatology unit (referral center). of K6hf, the type II cytokeratin exclusively expressed in the companion layer, was performed in 9 families. In Patients: A consecutive sample of 17 children (13 girls). 3 of these 9 families, a heterozygous glutamic acid and For 9 of them and their first-degree relatives, molecular lysine mutation, E337K, was identified in the L2 linker analyses were performed in the K6HF gene with 50 ap- region of K6HF. propriate controls. Conclusions: Diffuse partial woolly hair can be associ- Intervention: Minoxidil therapy (5% lotion) in 11 pa- ated with loose anagen hair syndrome.
    [Show full text]
  • Hair Loss in Infancy
    SCIENCE CITATIONINDEXINDEXED MEDICUS INDEX BY (MEDLINE) EXPANDED (ISI) OFFICIAL JOURNAL OF THE SOCIETÀ ITALIANA DI DERMATOLOGIA MEDICA, CHIRURGICA, ESTETICA E DELLE MALATTIE SESSUALMENTE TRASMESSE (SIDeMaST) VOLUME 149 - No. 1 - FEBRUARY 2014 Anno: 2014 Lavoro: 4731-MD Mese: Febraury titolo breve: Hair loss in infancy Volume: 149 primo autore: MORENO-ROMERO No: 1 pagine: 55-78 Rivista: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA Cod Rivista: G ITAL DERMATOL VENEREOL G ITAL DERMATOL VENEREOL 2014;149:55-78 Hair loss in infancy J. A. MORENO-ROMERO 1, R. GRIMALT 2 Hair diseases represent a signifcant portion of cases seen 1Department of Dermatology by pediatric dermatologists although hair has always been Hospital General de Catalunya, Barcelona, Spain a secondary aspect in pediatricians and dermatologists 2Universitat de Barcelona training, on the erroneous basis that there is not much in- Universitat Internacional de Catalunya, Barcelona, Spain formation extractable from it. Dermatologists are in the enviable situation of being able to study many disorders with simple diagnostic techniques. The hair is easily ac- cessible to examination but, paradoxically, this approach is often disregarded by non-dermatologist. This paper has Embryology and normal hair development been written on the purpose of trying to serve in the diag- nostic process of daily practice, and trying to help, for ex- ample, to distinguish between certain acquired and some The full complement of hair follicles is present genetically determined hair diseases. We will focus on all at birth and no new hair follicles develop thereafter. the data that can be obtained from our patients’ hair and Each follicle is capable of producing three different try to help on using the messages given by hair for each types of hair: lanugo, vellus and terminal.
    [Show full text]
  • Indicators of the Molecular Pathogenesis of Virulent Newcastle
    www.nature.com/scientificreports OPEN Indicators of the molecular pathogenesis of virulent Newcastle disease virus in chickens revealed by transcriptomic profling of spleen Mohammad Rabiei1*, Wai Yee Low2, Yan Ren2, Mohamad Indro Cahyono3, Phuong Thi Kim Doan1,4, Indi Dharmayanti3, Eleonora Dal Grande1 & Farhid Hemmatzadeh1,2 Newcastle disease virus (NDV) has caused signifcant outbreaks in South-East Asia, particularly in Indonesia in recent years. Recently emerged genotype VII NDVs (NDV-GVII) have shifted their tropism from gastrointestinal/respiratory tropism to a lymphotropic virus, invading lymphoid organs including spleen and bursa of Fabricius to cause profound lymphoid depletion. In this study, we aimed to identify candidate genes and biological pathways that contribute to the disease caused by this velogenic NDV-GVII. A transcriptomic analysis based on RNA-Seq of spleen was performed in chickens challenged with NDV-GVII and a control group. In total, 6361 genes were diferentially expressed that included 3506 up-regulated genes and 2855 down-regulated genes. Real-Time PCR of ten selected genes validated the RNA-Seq results as the correlation between them is 0.98. Functional and network analysis of Diferentially Expressed Genes (DEGs) showed altered regulation of ElF2 signalling, mTOR signalling, proliferation of cells of the lymphoid system, signalling by Rho family GTPases and synaptogenesis signalling in spleen. We have also identifed modifed expression of IFIT5, PI3K, AGT and PLP1 genes in NDV-GVII infected chickens. Our fndings in activation of autophagy-mediated cell death, lymphotropic and synaptogenesis signalling pathways provide new insights into the molecular pathogenesis of this newly emerged NDV-GVII. Newcastle disease virus (NDV) has a worldwide distribution.
    [Show full text]
  • Suv420h2 Ko Mice Show Enlarged Spleen
    Aus dem Adolf-Butenandt-Institut der Ludwig-Maximilians-Universität München Lehrstuhl:Molekularbiologie Direktor: Prof. Dr. Peter B. Becker Arbeitsgruppe: Prof. Dr. Gunnar Schotta The role of repressive chromatin functions during haematopoiesis Dissertation zum Erwerb des Doktorgrades der Naturwissenschaften (Dr. rer. nat.) an der Medizinischen Fakultät der Ludwig-Maximilians-Universität München vorgelegt von Alessandra Pasquarella aus Potenza 2014 II III Gedruckt mit Genehmigung der Medizinischen Fakultät der Ludwig-Maximilians-Universität München Betreuer: Prof. Dr. Gunnar Schotta Zweitgutachter: Prof. Dr. Rainer Haas Dekan: Prof. Dr. med. Dr. h. c. M. Reiser, FACR, FRCR Tag der mündlichen Prüfung: 16.04.2015 IV V Eidesstattliche Versicherung Ich erkläre hiermit an Eides statt, dass ich die vorliegende Dissertation mit dem Thema “The role of repressive chromatin functions during haematopoiesis” selbständig verfasst, mich außer der angegebenen keiner weiteren Hilfsmittel bedient und alle Erkenntnisse, die aus dem Schrifttum ganz oder annähernd übernommen sind, als solche kenntlich gemacht und nach ihrer Herkunft unter Bezeichnung der Fundstelle einzeln nachgewiesen habe. Ich erkläre des Weiteren, dass die hier vorgelegte Dissertation nicht in gleicher oder in ähnlicher Form bei einer anderen Stelle zur Erlangung eines akademischen Grades eingereicht wurde. ____________________ _____________________________ Ort, Datum Unterschrift Alessandra Pasquarella VI My doctoral work focused on the description and analysis of the role of repressive histone modifications during haematopoiesis. This thesis includes the three main projects which I followed during my PhD. Although two of them still require further investigation to be suitable for publication, the results described in the section “SETDB1-mediated silencing of MuLVs is essential for B cell development” have already been assembled in a manuscript which is ready for submission.
    [Show full text]
  • R‑Spondin Family Members As Novel Biomarkers and Prognostic Factors in Lung Cancer
    4008 ONCOLOGY LETTERS 18: 4008-4015, 2019 R‑spondin family members as novel biomarkers and prognostic factors in lung cancer LINGZHI WU1*, WEILI ZHANG2*, JINXIAN QIAN3, JIAN WU3, LIYANG JIANG3 and CHUNHUA LING4 1Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006; 2Department of Gastroenterology, Xiangcheng People's Hospital, Suzhou, Jiangsu 215131; 3Department of Intensive Care Unit, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu 215008; 4Department of Respiratory Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China Received November 29, 2018; Accepted May 15, 2019 DOI: 10.3892/ol.2019.10778 Abstract. The R-spondin (RSPO) family of secreted proteins Introduction consists of four members that have critical roles in embryonic development and organogenesis. However, the expression Lung cancer is one of the most fatal types of cancer in developed patterns and the exact roles of the individual RSPO family countries, and remains the leading cause of cancer-associated members in tumorigenesis and progression of lung cancer are mortality (1), with a higher mortality rate than prostate, breast unknown, particularly in non-small cell lung cancer, which and colon cancer combined, and with >1 million deaths expected accounts for 85% of all lung cancer cases. In the present study, per year worldwide (2). Although treatments for lung cancer data from the ONCOMINE database was used to compare the have improved in recent years, including surgery, chemotherapy, RNA expression levels of RSPOs in multiple different types radiation therapy, local treatment and targeted therapy, >50% of of cancer with normal controls.
    [Show full text]
  • University of California, San Diego
    UC San Diego UC San Diego Electronic Theses and Dissertations Title The post-terminal differentiation fate of RNAs revealed by next-generation sequencing Permalink https://escholarship.org/uc/item/7324r1rj Author Lefkowitz, Gloria Kuo Publication Date 2012 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO The post-terminal differentiation fate of RNAs revealed by next-generation sequencing A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Gloria Kuo Lefkowitz Committee in Charge: Professor Benjamin D. Yu, Chair Professor Richard Gallo Professor Bruce A. Hamilton Professor Miles F. Wilkinson Professor Eugene Yeo 2012 Copyright Gloria Kuo Lefkowitz, 2012 All rights reserved. The Dissertation of Gloria Kuo Lefkowitz is approved, and it is acceptable in quality and form for publication on microfilm and electronically: __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION Ma and Ba, for your early indulgence and support. Matt and James, for choosing more practical callings. Roy, my love, for patiently sharing the ups and downs
    [Show full text]
  • Uncombable Hair Syndrome
    Uncombable hair syndrome Author: Professor Ralph Trüeb1 Creation date: September 2003 Scientific editor: Professor Antonella Tosti 1 Leitender Arzt, Dermatologische Klinik, UniversitätsSpital Zürich, Gloriastrasse 31, 8091 Zürich, Switzerland. [email protected] Abstract Disease name and synonyms Definition Differential diagnosis Frequency Clinical description Management including treatment Etiology Diagnostic methods Genetic counseling Unresolved questions References Abstract Uncombable hair syndrome is a rare structural anomaly of the hair shaft with variable penetrance (MIM 191480). It may become first apparent from 3 months to 12 years of age. The hair is normal in quantity and is usually silvery-blond or straw-colored. It is disorderly, it stands out from the scalp, and cannot be combed flat. The underlying structural anomaly is longitudinal grooving of the hair shaft, which appears triangular or kidney-shaped in cross section. Affected individuals often have a negative family history, though the characteristic hair shaft anomaly can be demonstrated in asymptomatic family members by scanning electron microscopy. To be clinically apparent, 50 % of hairs must be affected by the structural abnormality. Spontaneous improvement often occurs in later childhood. Pili canaliculi have also been described associated with features of ectodermal dysplasia, and are a constant, though less pronounced finding, in the loose anagen hair syndrome. Autosomal-dominant inheritance is likely. The stiffness of the uncombable hair has been explained by the triangular form of the hair shaft in cross section. It has been suggested that the condition may result from premature keratinization of the inner root sheath. Diagnosis is suspected at clinical examination and confirmed through visualization of the hair shaft anomaly.
    [Show full text]
  • What Is Your Diagnosis?
    PHOTO QUIZ What Is Your Diagnosis? IMAGE NOT IMAGE NOT AVAILABLE ONLINE AVAILABLE ONLINE A 4-year-old girl presented to the dermatology clinic for the treatment of bullous impetigo. Examination revealed resolving angular cheilitis with secondary impetiginization, as well as frizzy, blond, unkempt-appearing shoulder-length hair. The patient’s parents reported that the girl’s hair was difficult to comb and had been unmanageable since birth. The patient is the offspring of nonconsanguineous parents and was the product of a healthy pregnancy. She was born at 38 weeks’ gestation by uncomplicated vaginal delivery and had experienced healthy growth and development. There was no known family history of hair disease. PLEASE TURN TO PAGE 31 FOR DISCUSSION Heidi F. Anderson, MD, University of Virginia School of Medicine, Charlottesville. Cheryl L. Lonergan, MD, Department of Dermatology, University of Virginia. Hina S. Qureshi, MD, Department of Pathology, University of Virginia. Kelly M. Cordoro, MD, Department of Dermatology, University of Virginia. The authors report no conflict of interest. 20 CUTIS® Photo Quiz Discussion The Diagnosis: Uncombable Hair Syndrome irst described in 1973 by Dupre et al1 as cheveux incoiffables and also now known as spun glass F hair and pili trianguli et canaliculi, uncomb- able hair syndrome is characterized by dry, frizzy, silvery blond to light brown hair that does not lay flat on the head. Typically, the hair is noncompliant with attempts at management by a comb or brush.2 Uncombable hair syndrome presents in infancy or during adolescence in rare cases.3 Hair grows at a slow to average rate, and the syndrome is not associ- IMAGE NOT ated with any hair loss or fragility.4 Both inherited AVAILABLE ONLINE (autosomal dominant gene with incomplete pen- etrance) and sporadic forms have been described,5 though the genetic or biochemical changes underly- ing this condition have yet to be determined.6 The exact prevalence of uncombable hair syndrome is unknown.
    [Show full text]
  • 1 Novel Expression Signatures Identified by Transcriptional Analysis
    ARD Online First, published on October 7, 2009 as 10.1136/ard.2009.108043 Ann Rheum Dis: first published as 10.1136/ard.2009.108043 on 7 October 2009. Downloaded from Novel expression signatures identified by transcriptional analysis of separated leukocyte subsets in SLE and vasculitis 1Paul A Lyons, 1Eoin F McKinney, 1Tim F Rayner, 1Alexander Hatton, 1Hayley B Woffendin, 1Maria Koukoulaki, 2Thomas C Freeman, 1David RW Jayne, 1Afzal N Chaudhry, and 1Kenneth GC Smith. 1Cambridge Institute for Medical Research and Department of Medicine, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, UK 2Roslin Institute, University of Edinburgh, Roslin, Midlothian, EH25 9PS, UK Correspondence should be addressed to Dr Paul Lyons or Prof Kenneth Smith, Department of Medicine, Cambridge Institute for Medical Research, Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0XY, UK. Telephone: +44 1223 762642, Fax: +44 1223 762640, E-mail: [email protected] or [email protected] Key words: Gene expression, autoimmune disease, SLE, vasculitis Word count: 2,906 The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in Annals of the Rheumatic Diseases and any other BMJPGL products to exploit all subsidiary rights, as set out in their licence (http://ard.bmj.com/ifora/licence.pdf). http://ard.bmj.com/ on September 29, 2021 by guest. Protected copyright. 1 Copyright Article author (or their employer) 2009.
    [Show full text]